LIVERMORE, Calif., Aug. 12, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel cell and hydrogen technology space, announced today that it has entered into a new enhanced license agreement […]
Planned IPO Aligns with Aditxt’s Acquire, Build and Capitalize (ABC) Monetization Framework MOUNTAIN VIEW, Calif., July 29, 2025—-Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, […]
The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma […]
Winnipeg, Manitoba— July 22, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, provides an update on its equity investment strategy regarding North American, […]
NEW YORK, July 22, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced a CRADA (Cooperative Research and Development Agreement) with the U.S. Department of Veterans Affairs and Foundation for Atlanta Veterans […]
Winnipeg, Manitoba– – July 18, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, provides an update on progress at its uranium projects in […]
Plan Combines Bitcoin Treasury Strategy and Equity Line to Support 2026 Potential Monetization Events, Starting with Pearsanta’s Planned IPO MOUNTAIN VIEW, Calif.—Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health […]
Hoth Therapeutics’ HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key Opinion Leader (KOL) event on, at 3:30PM EST to […]
FORT WORTH, Texas, June 26, 2025 — Lottery.com Inc. (NASDAQ: LTRY, LTRYW) (“Lottery.com” or “the Company”), a leading technology company transforming the intersection of gaming, sports and entertainment, today announced it is advancing its global […]
*Hoth Therapeutics and Silo Pharma Launch Joint Venture to Commercialize VA-Invented Obesity Drug Targeting $100B+ Global Market Exclusive License from U.S. Department of Veterans Affairs to Advance GDNF-Based Therapy for Obesity and Fatty Liver Disease […]
FORT WORTH, Texas, June 24, 2025 (GLOBE NEWSWIRE) — Lottery.com Inc. (NASDAQ: LTRY, LTRYW) (“Lottery.com” or “the Company”), a leading technology company transforming the intersection of gaming, sports and entertainment, today announced the appointment of […]
LONDON, June 17, 2025 — Lottery.com Inc. (NASDAQ: LTRY, LTRYW) (“Lottery.com” or “the Company”), a leading technology company transforming the intersection of gaming, sports and entertainment, today announced the appointment of internationally celebrated actor, producer, […]
Viral Sharing of AI COMIC on TikTok and Facebook Signals Strong User Adoption and Community Engagement User Base in Japan and South Korea Grows 1,300%, Underscoring Commercial Success and Global Potential Cutting-Edge AI Capabilities and Smart Cloud Infrastructure are […]
FORT WORTH, Texas, June 23, 2025 — Lottery.com Inc. (NASDAQ: LTRY; LTRYW) (“Lottery.com” or “the Company”) received formal notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance […]
Developed to address EGFR inhibitor-induced skin toxicities in cancer patients NEW YORK, June 23, 2025— Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they will host a virtual Key Opinion Leader (KOL) event […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
